Male breast cancer

Nicole P. Sandhu, Marie Brid Mac Bride, Christina A. Dilaveri, Lonzetta Neal, David R. Farley, Charles L. Loprinzi, Dietlind L. Wahner-Roedler, Karthik Ghosh

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Male breast cancer is rare, and many patients and health care providers are not familiar with this entity. Although the underlying causes are not well understood, certain populations are at higher risk, including certain gene mutation carriers, men with Klinefelter syndrome, and certain ethnic groups. Male breast cancer typically presents at a later stage than female breast cancer. A palpable mass is the most common presentation, but nipple discharge or other nipple changes may be seen. Because the number of affected individuals is small, prospective trials have not been conducted; thus, treatment recommendations are typically taken from large trials involving female breast cancer populations. Although outcomes in male breast cancer were previously thought to be worse than female breast cancer outcomes, it appears that they are similar. Questions regarding the most effective surgical and adjuvant therapies remain. Mastectomy with axillary lymph node evaluation, adjuvant hormonal therapy, and chemotherapy are commonly used. Providers of health care to male patients must be aware of the possibility of breast cancer and appropriately evaluate any suspicious changes.

Original languageEnglish (US)
Pages (from-to)146-153
Number of pages8
JournalJournal of Men's Health
Issue number3
StatePublished - Sep 1 2012


  • Breast neoplasms, male
  • Diagnosis
  • Disease management
  • Risk
  • Treatment outcome

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Male breast cancer'. Together they form a unique fingerprint.

Cite this